Archive for the ‘Mens Health’ Category

Levitra

Thursday, September 6th, 2007

 It is a round shaped orange tablet with strengths of 5mg, 10mg or 20mg. It is an oral tablet, which is swallowed. It is not an aphrodisiac and does not increase sexual desire.  For Levitra to be effective, sexual stimulation is required.

Levitra works by helping to relax the blood vessels in the penis, allowing blood to flow into the penis causing an erection. Levitra will not give a man an erection spontaneously, it will only help a man to get an erection if he is sexually stimulated.

Viagra use and sexual risk among HIV-seropositive men who have sex with men.

Wednesday, March 28th, 2007

BACKGROUND: Viagra may be used medically to treat erectile dysfunction or used recreationally to enhance sexual performance. Little is known about predictors of Viagra use among HIV-seropositive (HIV+) men who have sex with men (MSM), whether it is used with contraindicated substances, and the relationship with sexual risk. METHODS: A community-based sample of 1168 HIV+ MSM (55% men of color) from two large cities in the U.S. completed an A-CASI interview about their sexual practices and substance use in the past 3 months. In univariate analyses, Viagra use was associated with demographics, health status, substance use, and sexual risk. Logistic regression was conducted to predict Viagra use, with significant univariate predictors entered. RESULTS: One in eight men (12%) used Viagra, and many reported using contraindicated illicit substances (inhalants=53%) or HIV medications (indinavir=19%). In logistic regression, predictors of Viagra use were being older (OR, 1.06, 95% CI, 1.03-1.09), having education beyond high school (OR, 2.25, 95% CI, 1.16-4.36), taking HIV medications (OR, 1.98, 95% CI, 1.05-3.72), using any illicit substance (OR, 1.92, 95% CI, 1.16-3.18), using ketamine (OR, 2.82, 95% CI, 1.09-7.32), engaging in unprotected oral insertive intercourse (UOI) with HIV-negative or unknown serostatus non-main partners (OR, 1.88, 95% CI, 1.15-3.09), and engaging in unprotected anal insertive intercourse (UAI) with HIV-positive non-main partners (OR, 2.39, 95% CI, 1.33-4.31). CONCLUSIONS: Many HIV+ MSM used Viagra, particularly substance using men. Use of contraindicated illicit and prescribed medications was common. Viagra use was associated with UOI (but not UAI) with non-main partners who might be at risk of contracting HIV. With HIV+ non-main partners, Viagra users were more likely to engage in UAI. Providers should educate HIV+ Viagra users about potential interactions with other substances and provide counseling to reduce HIV and STD risks. Publication Types:

  • Meeting Abstracts

Keywords:

  • Acquired Immunodeficiency Syndrome
  • HIV Infections
  • HIV Seropositivity
  • Humans
  • Male
  • Piperazines
  • Sexual Behavior
  • Substance-Related Disorders
  • United States
  • sildenafil